The presence of IgA antibodies against these antigens has been predominantly determined in the sera of CD patients, with a prevalence of 55%, whereas in cases of UC patients, non-IBD colitis, and healthy individuals, the prevalence was much lower. The gene discussed is CD79A; the disease is irritable bowel syndrome.